India and the UAE are natural partners for healthcare groups with regional ambitions. Capital, clinicians and patients already move between the two, and many Indian-founded groups have built substantial UAE businesses. The momentum is visible. According to recent reports, Aster DM Healthcare announced a plan to invest in International Modern Hospital in Dubai as part of a commitment of more than AED 1 billion in the UAE over five years. If approved, this would take its UAE network to 11 hospitals. Forbes Middle East’s 2026 healthcare leaders list shows how concentrated the opportunity is, with the UAE home to 18 of the 50 founders and shareholders it features.
But the two markets run on very different rules. They differ in how health records are identified and shared, how insurance claims move, what the law says about where patient data can live, and which regulator a facility answers to. A group that treats them as one market with two postcodes will run into these differences after go-live, when they are most expensive to fix.
Two Different Digital Health Architectures
India has built a centralized, identity-led digital health system. The Ayushman Bharat Digital Mission (ABDM) is organized around the ABHA, a 14-digit health ID, and its scale is significant. As of July 2026, more than 93.95 crore ABHA numbers were created, over 105 crore health records were linked, and 2.72 lakh healthcare facilities were using ABDM-enabled software. In a reply in the Lok Sabha, the Union Health Minister put the national figure at 95.99 crore ABHA IDs as of 31 July 2026. For an Indian hospital, ABDM readiness is becoming part of standard operations.
The UAE’s model is federated. Abu Dhabi’s Department of Health (DOH) runs the Malaffi health information exchange. Dubai Health Authority (DHA) runs NABIDH. The Ministry of Health and Prevention (MOHAP) operates Riayati, which serves the Northern Emirates. A facility connects to the exchange tied to its licensing authority, and a group operating in several emirates may need to connect to more than one.
Anyone building a platform roadmap for both countries should note the consequences:
- India has one national identity and record-sharing framework to align with.
- The UAE has several parallel, regulator-specific exchanges.
- Integration work therefore does not transfer neatly from one country to the other. A hospital that is “interoperability-ready” in India is not automatically ready for Malaffi or NABIDH.
Insurance Works Differently, So Revenue Cycles Cannot Be Copied
Revenue cycle design is where cross-border groups most often underestimate the gap.
India: Insurance coverage is expanding fast but remains uneven. The National Sample Survey’s 80th round, published by the Ministry of Statistics in April 2026, found coverage of 47.4% in rural and 44.3% in urban areas in 2025. In 2017-18 the figures were 14.1% and 19.1%. Government-sponsored schemes account for most enrolments.
Claims volumes are large, but settlement quality is still an issue. Business Standard reports that in 2024-25 insurers settled ₹94,247 crore across 32.6 million health claims. IRDAI’s chairperson noted that the share of claimed amounts actually settled remains below expectations. India’s National Health Claims Exchange (NHCX) is meant to standardize this exchange. According to a Ministry of Health press release, 34 insurers and TPAs were live on it as of July 2024, with roughly 300 hospitals ramping up to submit claims. A typical Indian hospital handles a mix of self-pay, TPA-managed private insurance and government schemes.
UAE: The model is insurance-first. Mandatory health insurance for most of the population means nearly every non-emergency encounter involves eligibility checks, pre-authorization and a claim. The volumes are substantial. Dubai’s health insurance system handled 49.6 million claims in 2025, up from 43.69 million in 2024. In the Northern Emirates, Riayati logged nearly 4.9 million pre-approval requests in the period since its April 2022 launch. Turnaround expectations are now explicit and tight. Under a Dubai Health Insurance Corporation (DHIC) claims management directive effective 16 November 2025, providers must submit pre-authorization requests within one hour of the physician’s order. Insurers and TPAs must respond within 6 hours for elective outpatient cases, 24 hours for elective inpatient cases, and immediately for emergencies. The directive applies to insurers, TPAs and providers operating in Dubai, with the Dubai Government Insurance Program exempt. It also requires electronic claims submission through eClaimLink, and late submissions can attract delay fees of 0.03% of the net claimed amount per day.
For a multi-country group, the practical implications are:
- Pre-authorization workflows carry more weight in the UAE, where they shape almost every visit.
- Payer mix differs sharply. India’s blend of self-pay, TPA and government-scheme billing has no direct UAE equivalent.
- Denial patterns are driven by different causes, so analytics and rules built on one country’s data will mislead in the other.
A revenue cycle platform for both markets needs country-specific claims logic on top of a shared financial backbone, not one workflow stretched across both.
Data Protection: Consent in India, Localization in the UAE
This is the area with the biggest architectural consequences, and the one most often discovered late.
India: consent-led, with deadlines close. The Digital Personal Data Protection Rules were notified on 13 November 2025, starting a phased rollout over 18 months. The consent manager framework is a key near-term milestone. EY India notes that consent manager obligations apply 12 months after notification, which puts that milestone in mid-November 2026, less than four weeks from now. Hospitals will need to rework notices, consent capture and breach-response processes accordingly.
UAE: localization by default. Federal Law No. 2 of 2019 (the Health Data Law) sets a different starting point. Article 13 by default prohibits transferring, storing, generating or processing outside the UAE any health data relating to services provided in the UAE. A 2021 ministerial resolution created exceptions. The U.S. International Trade Administration describes ten categories that health authorities can grant case by case, including insurance claims administration, treatment overseas, telemedicine and research.
Abu Dhabi has taken a notably strict line. Licensed entities are restricted from exporting health data outside the UAE and from sharing it with third parties, even if de-identified, without DOH authorization. A US-UAE Business Council summary of a May 2025 session with DOH officials notes that exceptions can be granted for set periods, but the expectation is eventual full localization of data and processing.
There is one useful boundary. Article 13 restriction does not apply to the extent a UAE service processes data derived from healthcare provided overseas. In plain terms, data from patients treated in India is not caught by the UAE restriction merely because it is processed in a UAE environment, while UAE patient data generally must stay in the UAE.
This has direct implications for how a group builds its technology estate:
- A single global cloud instance serving both countries is likely to conflict with UAE localization expectations.
- UAE patient data should sit in a UAE-hosted environment, with clear tenant separation from India.
- Group-level reporting needs careful design. If consolidated dashboards pull UAE data into a global warehouse, even in aggregated or de-identified form, confirm with legal counsel and the relevant authority whether that is permissible.
These are general observations, not legal advice. Groups should take advice from UAE and Indian counsel before finalizing architecture.
Regulation Is Layered Inside the UAE Itself
Indian groups often arrive expecting “the UAE regulator.” There is no single one. Abu Dhabi is regulated by DOH, Dubai by DHA, and the Northern Emirates by MOHAP, each with its own licensing, reporting expectations and exchange platform. The U.S. International Trade Administration also notes that Dubai Healthcare City has some regulatory autonomy and its own Health Data Protection Regulation.
For a group planning facilities in more than one emirate, every new location can bring a new regulator, a different exchange to connect to and different claims infrastructure. Expansion cost is better measured in regulators than in facilities.
Accreditation adds another layer. The UAE has more JCI-accredited healthcare organizations than any other country, so international accreditation is close to a baseline expectation among patients and payers. Indian groups used to NABH-led quality frameworks should plan for JCI-style documentation and audit trails to be captured as part of daily workflow.
What Multi-Country Groups Should Do Before Expanding
Based on the differences above, a practical preparation checklist looks like this:
- Map regulators before sites. List the authority, health information exchange and claims infrastructure for every planned location, then build the integration roadmap from that list.
- Design data architecture around residency from day one. Decide early which data must stay in-country, and build separate regional environments rather than retrofitting them later.
- Standardize the core, localize the edges. Keep clinical, financial and master-data models consistent across countries, but configure compliance, claims and consent logic per market.
- Rebuild the revenue cycle per market. Treat India’s TPA and scheme billing and the UAE’s pre-authorization-driven claims as separate workflows with a shared reporting layer.
- Plan for consent and security as product features. DPDP consent management in India and Health Data Law controls in the UAE should be built into the platform, not handled by policy documents alone.
- Invest in training for multinational teams. UAE clinical and administrative teams are often drawn from many nationalities, so role-based onboarding matters as much as configuration.
- Phase go-lives to protect compliance continuity. Regulatory reporting, such as Malaffi or NABIDH submissions in the UAE and ABDM record-linking in India, should not lapse during migration.
Where a Connected Platform Fits
The common failure in cross-border expansion is stitching together a separate system per country and discovering later that leadership cannot see the whole group. A connected healthcare platform that supports both markets lets a group standardize clinical and financial workflows while configuring each country’s regulatory, claims and consent requirements locally. That is the approach Lifetrenz takes, supporting hospitals, clinics, diagnostics and healthcare networks across India and the UAE through one unified ecosystem. Details such as hosting model and data residency should be confirmed against each deployment’s regulatory requirements.
The Bottom Line
India and the UAE both reward healthcare groups that scale thoughtfully, but they reward different disciplines. India demands readiness for a national digital health identity, evolving consent rules and a varied payer landscape. The UAE demands fluency in multiple regulators, insurance-first claims and strict health data residency. Groups that map these differences before expanding, and build technology to match, avoid the expensive surprises that tend to arrive after the first facility goes live.
